Pharmafile Logo
Pharmafocus logo
Advanced Search

Merck KGaA announces new Senior Vice President, Head of Global Affairs

July 26, 2018
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Dr Maria Rivas, Germany, Merck, Merck KGaA, research and development

Merck KGaA has announced the appointment of Dr Maria Rivas as Senior Vice President, Head of Global Affairs. Dr Rivas, …

Appointment

Gilead’s CEO and Chairman to both step down before year’s end

July 26, 2018
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Gilead, pharma

Gilead has announced that its President and Chief Executive Officer Dr John Milligan (pictured) will be stepping down by the …

News

AstraZeneca announces price freezes while earnings drop by 28%

July 26, 2018
Business Services, Sales and Marketing AstraZeneca, Trump, price freezes, price hikes

The Anglo-Swedish drug maker AstraZeneca has joined Pfizer and others in halting price hikes until the end of 2018. AstraZeneca …

News
394px-ad_versus_co

Eisai and Biogen’s Alzheimer’s drug slows progression in Phase 2 trials

July 26, 2018
Research and Development Alzheimer's disease, BAN2401, Biodgen, Eisai, phase 2, research

An experimental drug developed by the Massachusetts-based multinational Biogen and their Japanese partner Eisai has been shown to significantly slow …

News
Matt Hancock

NHS to stockpile drugs in preparation for no-deal Brexit

July 25, 2018
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing NHS, brexit, government, pharma, stockpiling

Secretary of State for Health and Social Care, Matt Hancock, has said that the NHS is preparing to stockpile medicines …

News

FDA approves first endometriosis pain management drug in a decade

July 25, 2018
Research and Development, Sales and Marketing AbbVie, FDA, Neurocrine Biosciences, endometriosis, pharma

The FDA has confirmed its approval of AbbVie and Neurocrine Biosciences’ Orilissa (elagolix), a nonpeptide small molecule gonadotropin-releasing hormone (GnRH) …

News

HPV vaccine to be given to boys in England

July 25, 2018
Research and Development Cancer, HPV, infectious disease, sexually transmitted diseases, vaccines, virus

The government has announced that boys in England aged 12 and 13 will be vaccinated against Human Papilloma Virus (HPV) …

News

Pfizer to build $465m sterile injectable plant in Michigan

July 25, 2018
Manufacturing and Production, Research and Development Michigan, Pfizer, US, manufacturing, pharma

Pfizer has unveiled plans to invest $465 million to build a new sterile injectables plant in Portage, Michigan, saying that …

News

More antidepressants being prescribed to children in UK

July 25, 2018
Research and Development antidepressants, children, mental health, prescription, young people

Figures have revealed a trend towards an increased number of prescriptions for antidepressants for children in England, Scotland, and Northern …

News

Eleven babies dead after Dutch viagra trial

July 25, 2018
Research and Development Netherlands, clinical trial, deaths, premature, viagra

A trial of the drug sildenafil, commonly sold under the brand name Viagra, has been halted immediately after the death …

News
stana-moisescu-appointment

Teva Romania announces new general manager

July 24, 2018
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Israeli multinational Teva Pharmaceuticals have announced the appointment of Stana Moisescu as the General Director of Teva Romania, the company’s …

Appointment
murdo_gordon-bio

Bristol Myers Squibb announces departure of Chief Commercial Officer

July 24, 2018
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Bristol-Myers Squibb, bristol myers squibb, commerical executive, marketing, sales

Bristol Myers Squibb has announced that Executive Vice President and Chief Commercial Officer, Murdo Gordon, who has been with the …

Appointment
celgene_building

Celgene’s Revlimid combo meets Phase 3 goal in relapsed/refractory indolent lymphoma

July 24, 2018
Manufacturing and Production, Research and Development Celgene, Revlimid, lymphoma, pharma

Celgene has lifted the curtain on new Phase 3 data for its combo of Revlimid (lenalidomide) plus rituximab (R2) in …

News
25870220061_456a80df07_z

Employees protest against shutting down of GSK facility in Bangladesh

July 24, 2018
Manufacturing and Production Bangladesh, GSK, manufacturing, protest, union

Employees of the British multinational GlaxoSmithKline (GSK) have led a protest against the shutting down of manufacturing facilities in Bangladesh. …

News

Scientists launch free, open access, antibiotics database to tackle AMR

July 24, 2018
Manufacturing and Production AMR, Antibiotics, Database, academia, resistance

A team of scientists, led by Professor Laura Piddock from the University of Birmingham, have launched a free, open access, …

News
astrazeneca_plaque

AstraZeneca jettisons European heart drug rights for $210m

July 24, 2018
Manufacturing and Production, Sales and Marketing AstraZeneca, Atacand, Cheplapharm, blood pressure, heart failure, pharma

AstraZeneca has announced its intention to hand over the European commercial rights to its heart failure and blood pressure treatment …

News
mosquito-1016254_1280

First new treatment for reccurent malaria approved in over 60 years

July 23, 2018
Manufacturing and Production FDA, GSK, approval, malaria, p.vivax

The FDA has approved GSK’s Krintafel for the treatment of a recurring form of malaria in patients aged 16 and …

News
512px-antibiotic_sensitvity_and_resistance

The mission against antimicrobial resistance

July 23, 2018
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing antibiotic resistance, antimicrobial resistance, feature, pharma

Two headlines have highlighted the ‘here and now’ of the threat of rising antimicrobial resistance (AMR), writes Dr Peter Jackson.A …

Feature

FDA approves Agios’ oral leukaemia treatment Tibsovo

July 23, 2018
Sales and Marketing FDA, agios, approval, pharmaceuticals, tibsovo

The oral leukaemia treatment Tibsovo (ivosidenib) produced by Massachusetts-based Agios Pharmaceuticals has been approved for treatment of adult patients with …

News
allergan

US court overturns Allergan’s controversial attempts to avoid Restasis patent review

July 23, 2018
Sales and Marketing Allergan, Mylan, Restasis, US, dry eye, pharma

The US Court of Appeals for the Federal Circuit has seen fit to authorise a US Patent and Trademark Office …

News
The Gateway to Local Adoption Series

Latest content

Historic UN declaration supporting mental health – treatment to be given similar priority to chronic diseases

January 30, 2026

Rare diseases – spinal muscular atrophy

January 30, 2026

Could targeting the molecular causes of infertility finally transform IVF success rates?

January 29, 2026

Digital mental health technologies – a valuable tool in supporting people with depression and anxiety

January 29, 2026

Barts Health NHS Trust collaborates with H.I.G. Realty on healthcare innovation building

January 29, 2026